Concepedia

Maria E. Cabanillas

ME

125

Publications

12.2K

Citations

59

H-Index

2007

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Massachusetts General Hospital

The Ohio State University

Institut Gustave Roussy

Maria E. Cabanillas is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2007–2024

125

Publications

125

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic <i>BRAF</i> V600–Mutant Anaplastic Thyroid Cancer

Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg et al. · Journal of Clinical Oncology · 2017 · 848 citations · Full text

, , +15

Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers

Lori J. Wirth, Eric J. Sherman, Bruce Robinson et al. · New England Journal of Medicine · 2020 · 731 citations · Full text

Thyroid Cancer

Laura Boucai, Mark Zafereo, Maria E. Cabanillas · JAMA · 2024 · 474 citations

Selective RET kinase inhibition for patients with RET-altered cancers

Vivek Subbiah, Vamsidhar Velcheti, Brian B. Tuch et al. · Annals of Oncology · 2018 · 422 citations · Full text

Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial

Marcia S. Brose, Maria E. Cabanillas, Ezra E.W. Cohen et al. · The Lancet Oncology · 2016 · 376 citations · Full text

, , +4

Rows per page

1–5 of 125